We are live on
!
Find out more
Marsico Capital Management Portfolio holdings
AUM
$3.83B
Turnover
32.5%
1-Year Est. Return
63.68%
This Fund
S&P 500
This Quarter
Est. Return
+6.47%
1 Year Est. Return
+63.68%
3 Year Est. Return
+288.07%
5 Year Est. Return
+405.68%
10 Year Est. Return
+2,460.26%
AUM
$15.9B
AUM Growth
–
Cap. Flow
+$15.9B
Cap. Flow
% of AUM
99.53%
Top 10 Holdings %
Top 10 Hldgs %
37.48%
Holding
97
New
97
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$888M |
| 2 |
Biogen
BIIB
|
+$854M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$688M |
| 4 |
MON
Monsanto Co
MON
|
+$612M |
| 5 |
Citigroup
C
|
+$580M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 23.6% |
| 2 | Financials | 15.96% |
| 3 | Healthcare | 13.37% |
| 4 | Industrials | 12.33% |
| 5 | Communication Services | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$195B
| $873M | 5.48% |
+17,041,344
| New | +$888M |
2013 Q2
0 quarters
|
|
|
2
Biogen
BIIB
$34.8B
| $860M | 5.4% |
+3,997,754
| New | +$854M |
2013 Q2
0 quarters
|
|
|
3
Alphabet (Google) Class C
GOOG
$4.22T
| $713M | 4.48% |
+32,515,461
| New | +$688M |
2013 Q2
0 quarters
|
|
|
4
Citigroup
C
$207B
| $579M | 3.63% |
+12,062,151
| New | +$580M |
2013 Q2
0 quarters
|
|
|
MON
5
DELISTED
Monsanto Co
MON
| $578M | 3.63% |
+5,846,658
| New | +$612M |
2013 Q2
0 quarters
|
|
6
Visa
V
$750B
| $546M | 3.43% |
+11,961,552
| New | +$523M |
2013 Q2
0 quarters
|
|
7
Home Depot
HD
$308B
| $472M | 2.96% |
+6,090,738
| New | +$458M |
2013 Q2
0 quarters
|
|
|
PCP
8
DELISTED
PRECISION CASTPARTS CORP
PCP
| $466M | 2.93% |
+2,063,887
| New | +$418M |
2013 Q2
0 quarters
|
|
9
American International
AIG
$41.4B
| $462M | 2.9% |
+10,340,634
| New | +$444M |
2013 Q2
0 quarters
|
|
10
AB InBev
BUD
$160B
| $420M | 2.63% |
+4,649,544
| New | +$443M |
2013 Q2
0 quarters
|
|
11
Accenture
ACN
$138B
| $415M | 2.61% |
+5,767,422
| New | +$458M |
2013 Q2
0 quarters
|
|
12
Wynn Resorts
WYNN
$7.93B
| $409M | 2.57% |
+3,193,035
| New | +$426M |
2013 Q2
0 quarters
|
|
13
TJX Companies
TJX
$159B
| $407M | 2.56% |
+16,258,894
| New | +$401M |
2013 Q2
0 quarters
|
|
14
Union Pacific
UNP
$172B
| $399M | 2.51% |
+5,175,222
| New | +$390M |
2013 Q2
0 quarters
|
|
15
eBay
EBAY
$54.7B
| $387M | 2.43% |
+17,790,611
| New | +$403M |
2013 Q2
0 quarters
|
|
16
AutoZone
AZO
$49.5B
| $381M | 2.39% |
+899,041
| New | +$367M |
2013 Q2
0 quarters
|
|
17
Wells Fargo
WFC
$248B
| $378M | 2.37% |
+9,156,662
| New | +$357M |
2013 Q2
0 quarters
|
|
18
Canadian Pacific Kansas City
CP
$76.4B
| $373M | 2.34% |
+15,364,350
| New | +$387M |
2013 Q2
0 quarters
|
|
19
Walt Disney
DIS
$191B
| $341M | 2.14% |
+5,401,890
| New | +$341M |
2013 Q2
0 quarters
|
|
20
Nike
NKE
$55.2B
| $333M | 2.09% |
+10,474,172
| New | +$326M |
2013 Q2
0 quarters
|
|
21
Bristol-Myers Squibb
BMY
$124B
| $331M | 2.08% |
+7,410,629
| New | +$322M |
2013 Q2
0 quarters
|
|
22
Starbucks
SBUX
$110B
| $308M | 1.93% |
+9,401,004
| New | +$292M |
2013 Q2
0 quarters
|
|
23
Kinder Morgan
KMI
$73.1B
| $297M | 1.86% |
+7,774,677
| New | +$302M |
2013 Q2
0 quarters
|
|
24
SLB Ltd
SLB
$71.8B
| $264M | 1.66% |
+3,689,167
| New | +$273M |
2013 Q2
0 quarters
|
|
25
American Express
AXP
$212B
| $254M | 1.59% |
+3,397,346
| New | +$242M |
2013 Q2
0 quarters
|
|
Similar funds
Marsico Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Marsico Capital Management, which disclosed 97 positions worth $15.9B. Its ten largest holdings account for 37% of the portfolio.
Its largest position is Gilead Sciences: 17,041,344 shares worth $873M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, followed by Financials and Healthcare.
- Marsico Capital Management's largest Q2 2013 buy was Gilead Sciences: 17,041,344 shares worth $873M.
- Marsico Capital Management's ten largest holdings make up 37% of its $15.9B portfolio in Q2 2013.
- Marsico Capital Management disclosed 97 positions in Q2 2013, its first 13F filing on record.
Based on Marsico Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.